Early microvascular changes with loss of the glycocalyx in children with type 1 diabetes

Claudia Nussbaum1, Ana Cavalcanti Fernandes Heringa1, Zuzana Mormanova1

  • 1Division of Neonatology IS, Dr. von Hauner Children's Hospital, University Children's Hospital Munich, Munich, Germany.

The Journal of Pediatrics
|December 26, 2013
PubMed

Insights

Children with type 1 diabetes show early microvascular changes and glycocalyx loss, even without clinical signs of diabetic microangiopathy. These findings suggest the glycocalyx can help detect complications earlier.

Area of Science:

  • Pediatric Endocrinology
  • Vascular Biology
  • Diabetes Research

Background:

  • Type 1 diabetes mellitus (T1DM) can lead to microvascular complications.
  • Early detection of diabetic microangiopathy is crucial for timely intervention.
  • Subclinical microcirculatory changes may precede overt clinical manifestations.

Purpose of the Study:

  • To investigate microcirculatory alterations and glycocalyx integrity in children with T1DM.
  • To assess for subclinical signs of diabetic microangiopathy.
  • To explore the potential of glycocalyx thickness as an early biomarker.

Main Methods:

  • Sidestream dark field imaging of sublingual microcirculation in 14 children with T1DM and 14 controls.
  • Analysis of vessel density, surface coverage, diameter distribution, flow index, and glycocalyx thickness.
  • Statistical analysis using Wilcoxon rank sum test and Pearson correlation.

Main Results:

  • Children with T1DM exhibited significantly reduced glycocalyx thickness (0.38 μm vs 0.60 μm) compared to controls.
  • Glycocalyx thickness was inversely correlated with blood glucose levels (r = -0.55; P = .003).
  • Increased percentage of larger vessels (>20 μm) and total vessel surface coverage was observed in children with T1DM.

Conclusions:

  • Microvascular alterations and glycocalyx loss are detectable in children with T1DM before clinical diabetic microangiopathy.
  • The glycocalyx serves as a potential monitoring measurement for early detection of diabetic microangiopathy.
  • These findings may inform new therapeutic strategies for protecting or restoring the glycocalyx.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K